NYSE:CNS

Cohn & Steers Stock News

Financial Services > Asset Management

Buy CNS

*Your capital is at risk

$80.79

-1.71 (-2.07%)

At Close: Jul 21, 2026

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For October 2024

04:23pm, Monday, 11'th Nov 2024

NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $89.7 billion as of October 31, 2024, a decrease of $2.0 billion from as

Cohen & Steers Announces Changes to Realty Indexes

04:05pm, Friday, 08'th Nov 2024

NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio In

Cohen & Steers Appoints Karen Wilson Thissen to Board of Directors

08:00am, Friday, 08'th Nov 2024

NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc.'s (NYSE: CNS) Board of Directors has appointed Karen Wilson Thissen as a director of the company. Ms. Thissen has also been appointed as a

Cohen & Steers, Inc. Declares Quarterly Dividend

04:24pm, Thursday, 07'th Nov 2024

NEW YORK , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the fourth quarter of 2024 in the amount of $0.59 per share of common

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

08:00am, Wednesday, 06'th Nov 2024

CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment

09:15am, Monday, 04'th Nov 2024

Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael Weller Access the segment here HOUSTON, TX / ACCESSWIRE / November 4, 2024 / CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

09:00am, Friday, 01'st Nov 2024

HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for prim

Elastic Enables Innovation in Next Generation Knowledge Management with LG CNS

06:00am, Friday, 01'st Nov 2024

SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI company, today announced its successful collaboration with LG CNS, a leading digital transformation company in Korea, to help transf

Corero Network Security Named Winner of the Coveted 2024 Top InfoSec Innovator Awards

09:00am, Thursday, 31'st Oct 2024

SmartWall ONE ™ Named a Hot Company DDoS Protection Solution by Cyber Defense Magazine MARLBOROUGH, Mass. , Oct. 31, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDoSF), the dis

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

07:37pm, Wednesday, 30'th Oct 2024

NEW YORK , Oct. 30, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by